240 related articles for article (PubMed ID: 15159303)
21. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
22. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center.
Shannon KM; Lubratovich ML; Finkelstein DM; Smith BL; Powell SN; Seiden MV
Cancer; 2002 Jan; 94(2):305-13. PubMed ID: 11900216
[TBL] [Abstract][Full Text] [Related]
23. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.
Hallowell N; Ardern-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M
Clin Genet; 2005 Jun; 67(6):492-502. PubMed ID: 15857416
[TBL] [Abstract][Full Text] [Related]
24. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
[TBL] [Abstract][Full Text] [Related]
25. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
Ardern-Jones A; Kenen R; Eeles R
Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
[TBL] [Abstract][Full Text] [Related]
26. Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
Schwartz MD; Hughes C; Roth J; Main D; Peshkin BN; Isaacs C; Kavanagh C; Lerman C
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482
[TBL] [Abstract][Full Text] [Related]
27. Coping with genetic testing for breast cancer susceptibility.
Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
[TBL] [Abstract][Full Text] [Related]
28. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
[TBL] [Abstract][Full Text] [Related]
29. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.
Keogh LA; Southey MC; Maskiell J; Young MA; Gaff CL; Kirk J; Tucker KM; Rosenthal D; McCredie MR; Giles GG; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2258-63. PubMed ID: 15598789
[TBL] [Abstract][Full Text] [Related]
30. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
31. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
Kotsopoulos J; Librach CL; Lubinski J; Gronwald J; Kim-Sing C; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Randall S; Manoukian S; Pasini B; Tung N; Ainsworth PJ; Cummings S; Sun P; Narod SA;
Cancer Causes Control; 2008 Dec; 19(10):1111-9. PubMed ID: 18509731
[TBL] [Abstract][Full Text] [Related]
32. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
Collins V; Meiser B; Gaff C; St John DJ; Halliday J
Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
[TBL] [Abstract][Full Text] [Related]
33. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
[TBL] [Abstract][Full Text] [Related]
34. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
35. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
[TBL] [Abstract][Full Text] [Related]
36. Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.
Dawson SJ; Price MA; Jenkins MA; McKinley JM; Butow PN; McLachlan SA; Lindeman GJ; Weideman P; Friedlander ML; Hopper JL; Phillips KA
J Clin Oncol; 2008 Jan; 26(2):225-32. PubMed ID: 18040054
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
38. Early adoption of BRCA1/2 testing: who and why.
Armstrong K; Weiner J; Weber B; Asch DA
Genet Med; 2003; 5(2):92-8. PubMed ID: 12644778
[TBL] [Abstract][Full Text] [Related]
39. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
Tambor ES; Rimer BK; Strigo TS
Am J Med Genet; 1997 Jan; 68(1):43-9. PubMed ID: 8986274
[TBL] [Abstract][Full Text] [Related]
40. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]